Clinical Trials Logo
  1. Home
  2. Borderline Personality Disorder
  3. NCT01343550
  4. Details
NCT01343550 Clinical Trial

Creativity Group for Borderline Personality Disorder

Borderline Personality Disorder Clinical Trial

Official title:
Creativity Group for Borderline Personality Disorder

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01343550
Other study ID # PHS6019
Secondary ID
Status Completed
Phase Phase 1
First received
Last updated
Start date February 2011
Est. completion date August 2011

Study information
Verified date February 2011
Source State University of New York - Upstate Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators hypothesize that a creativity skills group for Borderline Personality Disorder can reduce symptoms of BPD, depression, and anxiety.

Recruitment information / eligibility
Status Completed
Enrollment 20
Est. completion date August 2011
Est. primary completion date August 2011
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18 years of age or older - participant self-reports clinical diagnosis of Borderline Personality Disorder - currently seeing an individual therapist on a regular basis

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• creativity group
This is a creativity group intervention. There will be 4 groups. Each group has one session per week. Each session is a duration of two hours.

Locations
Country Name City State
United States SUNY Upstate Medical University Syracuse New York

Sponsors (1)
Lead Sponsor Collaborator
State University of New York - Upstate Medical University

Country where clinical trial is conducted

United States, 

References & Publications (2)

Gunderson JG. Borderline personality disorder: ontogeny of a diagnosis. Am J Psychiatry. 2009 May;166(5):530-9. doi: 10.1176/appi.ajp.2009.08121825. Review. — View Citation

Jacob GA, Gabriel S, Roepke S, Stoffers JM, Lieb K, Lammers CH. Group therapy module to enhance self-esteem in patients with borderline personality disorder: a pilot study. Int J Group Psychother. 2010;60(3):373-87. doi: 10.1521/ijgp.2010.60.3.373. — View Citation

Outcome
Type Measure Description Time frame Safety issue
Primary Borderline Evaluation of Severity Over Time (BEST) baseline, 5th week, post-intervention (week 8)
Secondary Beck Depression Inventory (BDI) baseline, week 5, week 8
See also
  Status Clinical Trial Phase
Recruiting NCT04856449 - DBT Skills Plus EMDR for BPD and Trauma N/A
Active, not recruiting NCT04587518 - Five Factor Model Treatment for Borderline Personality Disorder N/A
Recruiting NCT05651295 - A Precision Medicine Approach to Target Engagement for Emotion Regulation N/A
Completed NCT03677037 - The Short-Term MBT Project Phase 3
Not yet recruiting NCT05989529 - Delving Into Borderline Personality Disorder Clinical Trial Experiences
Completed NCT02068326 - MBT in Groups for Adolescents With BPD or Subthreshold BPD Versus TAU - the M-GAB Randomized Controlled Trial N/A
Completed NCT02518906 - Evaluation of AIT Study N/A
Recruiting NCT04296604 - Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations N/A
Terminated NCT02149823 - Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations Phase 1
Completed NCT02108990 - Acetaminophen and Social Processes Phase 2
Completed NCT01635556 - Evaluation of a Modified Dialectical Behavior Therapy Program N/A
Completed NCT02988037 - Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study N/A
Not yet recruiting NCT01683136 - Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Feasibility Study for the Treatment of Borderline Personality Disorder N/A
Completed NCT02397031 - Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder N/A
Terminated NCT01212588 - Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD) Phase 2
Terminated NCT01103180 - Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder Phase 2
Terminated NCT00539188 - N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD Phase 2
Recruiting NCT05398627 - Neurofeedback for Borderline Personality Disorder N/A
Recruiting NCT03994510 - SHame prOpensity in bOrderline Personality Disorder N/A
Recruiting NCT06005129 - Personality Change Study for Borderline Personality Disorder N/A